Foley & Lardner LLP
Records under this name other than the patents Foley & Lardner LLP holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,367,864 | Dimeric double metal salts of (−)-hydroxycitric acid, methods of making and uses of same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,638,795 | Systems and Methods for Quality of Service of Encrypted Network Traffic Formerly held In force · High confidence | In force | High confidence | |
| US 8,429,652 | Systems and Methods for Spillover in a Multi-Core System Formerly held In force · High confidence | In force | High confidence | |
| US 9,589,029 | Systems and Methods for Database Proxy Request Switching Formerly held In force · High confidence | In force | High confidence | |
| US 7,189,416 | Method for stable and controlled delivery of (-)-hydroxycitric acid Formerly held Term ended Term ended Mar 18, 2024 · From the USPTO record | Term ended | Term ended Mar 18, 2024 | From the USPTO record |
| US 8,394,856 | (-)-Hydroxycitric acid for controlling inflammation Formerly held Term ended Ended no later than Jul 2, 2023 · From the USPTO record | Term ended | Ended no later than Jul 2, 2023 | From the USPTO record |
| US 6,441,041 | (-)-hydroxycitric acid for the prevention of osteoporosis Formerly held Term ended Term ended Jun 20, 2021 · From the USPTO record | Term ended | Term ended Jun 20, 2021 | From the USPTO record |
| US 6,482,858 | (−)-hydroxycitric acid for wound healing and immunomodulation Formerly held Term ended Term ended Jun 20, 2021 · From the USPTO record | Term ended | Term ended Jun 20, 2021 | From the USPTO record |
| US 6,476,071 | Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acid Formerly held Term ended Term ended May 7, 2021 · From the USPTO record | Term ended | Term ended May 7, 2021 | From the USPTO record |
| US 7,015,250 | Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acid Formerly held Term ended Term ended Feb 13, 2021 · From the USPTO record | Term ended | Term ended Feb 13, 2021 | From the USPTO record |